Dr. Rachel Freedman comments on a study showing older black women with human epidermal growth factor receptor 2 (HER2)–positive breast cancer are less likely than their white peers to receive targeted therapy.
Dr. David A. Williams, president of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, comments on why pediatric cancers should be a priority for research funds.
Dr. Geoffrey Oxnard led a study showing how a simple blood test can help treat patients with certain lung cancers.
Dana-Farber nutritionist Stacy Kennedy talks about cancer patients balancing the advantage of taking fish oil with the potential risks.
Dr. Jennifer Ligibel talks about how healthy behaviors may be powerful tools in preventing cancer recurrence.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: